Work

Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors

Year: 2014

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-014-0176-4

Authors: Gerald S. Falchook, Jennifer J. Wheler, Aung Naing, Sarina A. Piha-Paul, Siqing Fu, Apostolia M. Tsimberidou, David S. Hong, Filip Janku, Ralph Zinner, Yunfang Jiang, Mei Huang, Quan Lin, Kristin Parkhurst, Razelle Kurzrock

Institutions: HealthONE, Presbyterian St. Luke's Medical Center, The University of Texas MD Anderson Cancer Center, University of California San Diego, Moores Cancer Center

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: Cancer Center Support Grant, Paul Calabresi Clinical Oncology Award

OpenAlex ID: W1978670801

FWCI: 0.41

Cites: 41

Cited by: 10

Related to: 10